Related Experiment Video
Updated: Sep 24, 2026

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis
Published on: April 10, 2019
Drug-Induced Enterocolitis Syndrome in Children: A Report of Two Cases
Helena Ferreira1, Joana Capela2, Ana Rita Araújo3
1Department of Pediatrics, Centro Materno Infantil do Norte, Unidade Local de Saúde de Santo António, Entidade Pública Empresarial, Porto, PRT.
Abstract:
Drug-induced enterocolitis syndrome (DIES) is a rare non-IgE-mediated hypersensitivity reaction characterized by delayed-onset gastrointestinal symptoms, typically occurring one to four hours after drug ingestion. It shares clinical features with food protein-induced enterocolitis syndrome and remains underrecognized, with limited reported cases. We present two pediatric cases of DIES triggered by amoxicillin. The first case involves an eight-year-old girl with allergic rhinoconjunctivitis and asthma, who experienced multiple episodes of vomiting and pallor following amoxicillin ingestion. A drug provocation test (DPT) with amoxicillin reproduced the reaction, with vomiting, lethargy, pallor, and diarrhea. The second case concerns a three-year-old girl, initially developing an urticarial rash after amoxicillin exposure at eight months of age. A subsequent DPT led to persistent vomiting, abdominal pain, and leukocytosis with neutrophilia, requiring intravenous fluid therapy. In both cases, DIES was diagnosed based on clinical criteria, and amoxicillin avoidance was recommended. These cases align with previously reported pediatric DIES, reinforcing its association with amoxicillin. Laboratory findings, including leukocytosis, neutrophilia, and thrombocytosis, may support the diagnosis, but clinical recognition remains crucial, requiring high suspicion and increased awareness among clinicians. These cases highlight the diagnostic challenges in differentiating DIES from IgE-mediated drug hypersensitivity, the importance of conducting DPT in a controlled setting, and the need for further research on its pathophysiology, biomarkers, and prognosis.
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Bacterial Gastroenteritis
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis

